Navigation Links
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Date:10/18/2007

one marrow and spleen, so selecting targets in these tissues is part of our strategy for developing effective drugs. We plan to move ISIS 388626 forward toward human proof-of-concept as rapidly as possible, and we look forward to continuing to populate our metabolic disease pipeline with drugs arising from our prolific research program."

ABOUT SGLT2 AND ISIS 388626

The sodium dependent glucose transporter type 2 (SGLT2) is substantially responsible for glucose re-absorption in the kidney. Decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive target for the treatment of diabetes. In preclinical studies, Isis has demonstrated in several animal species that ISIS 388626 and other antisense inhibitors of SGLT2 effectively reduce target mRNA levels, increase urinary glucose excretion and consequently lower blood glucose levels and HbA1c without causing dangerously low levels of blood sugar known as hypoglycemia. This is consistent with expectations based on human subjects who have mutations in the SGLT2 gene and have increased urine glucose levels but are otherwise asymptomatic. ISIS 388626 effectively and specifically inhibits the production of SGLT2 in the kidney tissue, without having any effect on a related gene product, SGLT1. In addition to being Isis' first second-generation antisense drug for a kidney target, ISIS 388626 is also unique due to its 12 nucleotide length rather than the more typical 18 - 21 nucleotide sequences that comprise Isis' other drugs. This attribute simplifies manufacturing and has the potential to substantially reduce related expenses. The short sequence may also contribute to ISIS 388626's unusually high potency; it is among the most potent antisense drugs Isis has yet evaluated in preclinical models.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The C
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 SeniorCare.com has published the ... reality problem Americans have regarding aging and long-term care ... care services as they age, 63% of Americans do ... In the report, Carol Marak of SeniorCare.com interviewed 44 ... Health Care Association and The Scan Foundation. The experts ...
(Date:4/28/2015)... FL (PRWEB) April 28, 2015 ... organization which provides vascular, electrocardiogram, echocardiogram, and NCV ... non-invasive vascular testing to help podiatrists diagnose peripheral ... challenging to diagnose PAD without the aid of ... Chief Medical Officer at Wimbledon Health Partners. ...
(Date:4/28/2015)... MO (PRWEB) April 28, 2015 The ... 2015 from 5:00 to 8:00 pm at the Sheraton Colonial ... than 50 hospitals, clinics and groups with career opportunities will ... represented. Attendees will enjoy free hors d’oeuvres and raffle prize ... PracticeMatch says “Boston is an ideal location to hold ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 The Awareness Counselor ... the common topic of judging. According to Awareness Counselor, there ... people, when directed outward, and to an individual who self-judges. ... new clients as a class or one one one talk. ... founder of Awareness Counselor, is that every being on earth ...
(Date:4/28/2015)... Aliso Viejo, CA (PRWEB) April 28, 2015 ... created for use in Final Cut Pro X ... attention to specific areas on-screen with classic buttons, animated ... Annotate is the perfect compliment to vlogs, video series, ... Cut Pro X 10.2 or newer. ProTube Annotate ...
Breaking Medicine News(10 mins):Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:FCPX plugin developer Pixel Film Studios releases Protube Annotate plugin for Final Cut Pro X. 2
... A Dartmouth-led study of young U.S. teens showed that ... items featuring an alcohol brand, and those who do ... drinking from susceptibility, to beginning drinking, to binge drinking, ... Archives of Pediatrics & Adolescent Medicine . , ...
... study finds , , TUESDAY, March 3 (HealthDay News) -- The ... the worse his sex life, a new study finds. , ... bypass surgery can help reverse those ills. , "Previous studies ... and can be associated with infertility, but we wanted to ...
... long-term investment and social responsibility in industry categoryMADISON, N.J., ... DGX ), the world,s leading provider of diagnostic testing, ... magazine,s list of the World,s Most Admired Companies. Quest ... "Pharmacy and Other Services." The 2009 ranking is the ...
... long-term care insurance. , ... Newark, NJ (PRWEB) March 3, 2009 -- ... you off, Prudential has a way out the maze. Prudential ... confuse the decision-making process., , , , ,Although its design is simpler, ...
... of the World,s Most Admired CompaniesEL SEGUNDO, Calif., March ... care services, today accepted the honor by FORTUNE ... facilities in the country. DaVita(R) ranked #1 in the ... Investment and Quality of Products and Services. Overall, the ...
... LITTLE FALLS, N.J., March 3 Cantel Medical Corp. (NYSE: ... discuss the Company,s results for its second quarter ended January ... Participating in the call will be Charles M. Diker, ... President and CFO; and Roy K. Malkin, President of Minntech ...
Cached Medicine News:Health News:Owning alcohol-branded merchandise associated with teen drinking behaviors 2Health News:Men's Sex Lives May Suffer as Waistlines Expand 2Health News:Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List 2Health News:Prudential Long-Term Care Product Simplifies Decisions 2Health News:Prudential Long-Term Care Product Simplifies Decisions 3Health News:FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality 2Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009 2
(Date:4/27/2015)... , April 27, 2015 NxStage Medical, Inc. ... products, today announced that Jeffrey H. Burbank , Chief ... Care Conference in Boston, MA on ... A webcast of the event will be made available ... About NxStage NxStage Medical, Inc. ...
(Date:4/27/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... for human disease, will release its first quarter 2015 ... financial markets close.  Lexicon management will hold a conference ... financial results for the first quarter 2015 at 5:00 ... The dial-in number for the conference call is 888-645-5785 ...
(Date:4/27/2015)... 27, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that it ... Food and Drug Administration ("FDA") verifying that the Company ... the warning letter it received from the FDA in ... re-inspection in March 2015 by the FDA at CryoLife,s ...
Breaking Medicine Technology:NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference 2Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2
... the new screening guidelines announced by the National,Comprehensive Cancer ... will encourage those at high risk for lung cancer ... LCA President Laurie Fenton Ambrose said that lung ... all the other major cancers combined,until more at risk ...
... ILE ) announced today the completion of ... Study IT-A-008 investigating the Isolagen,Therapy(TM) for the treatment ... be administered at seven clinical sites across the ... Therapy could hold great promise for the,treatment of ...
Cached Medicine Technology:Lung Cancer Alliance Commends NCCN on Screening Guidelines 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 3
... is a fully automated, benchtop coagulation ... and immunological assays in true random ... of sample management offers high throughput ... without the need to interrupt current ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
... The ACL 100 is ... volume workloads, or as a ... also runs clotting assays, such ... Plus, it's backed by superior ...
... StatSite MHgb test system is ... dedicated hemoglobin test system designed ... public health clinics, blood centers ... portable system is designed for ...
Medicine Products: